Anti-Jo-1 antibody: A marker for myositis with interstitial lung disease

R. M. Bernstein, S. H. Morgan, J. Chapman, C. C. Bunn, M. B. Mathews, M. Turner-Warwick, G. R. Hughes

Research output: Contribution to journalArticlepeer-review

189 Scopus citations

Abstract

An autoantibody known as anti-Jo-1 antibody is found in 25% of patients with myositis. Its prevalence in patients with both myositis and cryptogenic fibrosing alveolitis was 68% (13 out of 19 patients), compared with 7.5% in patients with myositis alone (four of 53) and 3% in patients with cryptogenic fibrosing alveolitis alone (two of 62). Anti-Jo-1 antibody may be useful in indicating patients with myositis and cryptogenic fibrosing alveolitis. Raynaud's phenomenon, the sicca syndrome, and mild arthritis are also often part of the syndrome.

Original languageEnglish (US)
Pages (from-to)151-152
Number of pages2
JournalBritish Medical Journal
Volume289
Issue number6438
DOIs
StatePublished - 1984
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Anti-Jo-1 antibody: A marker for myositis with interstitial lung disease'. Together they form a unique fingerprint.

Cite this